Improvement of Libman-Sacks Endocarditis With Combined Hydroxychloroquine-Vitamin K Antagonist Therapy in a Primary Antiphospholipid Syndrome Patient

Loukman Omarjee (1, 2) , Vincent Jaquinandi (1, 3) , Audrey Camarzana (2, 4) , Frederic Rouleau (2, 4) , Tin-Hinan Mezdad (2, 4) , Thierry Le Tourneau (5) , Guillaume Mahe (1, 3) , Cristina Belizna (2, 4)

1 CHU Pontchaillou [Rennes]
2 MITOVASC - MitoVasc - Physiopathologie Cardiovasculaire et Mitochondriale
3 CIC - Centre d'Investigation Clinique [Rennes]
4 CHU Angers - Centre Hospitalier Universitaire d'Angers
5 CHU Nantes - Centre hospitalier universitaire de Nantes

Domains: Life Sciences [q-bio]

Loukman Omarjee, Vincent Jaquinandi, Audrey Camarzana, Frederic Rouleau, Tin-Hinan Mezdad, et al.. Improvement of Libman-Sacks Endocarditis With Combined Hydroxychloroquine-Vitamin K Antagonist Therapy in a Primary Antiphospholipid Syndrome Patient. Circulation Journal, 2018, 82 (9), pp.2380-2382. ⟨10.1253/circj.CJ-17-1131⟩. ⟨hal-01879626⟩